Ad is loading...

ANTX AN2 Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology

Get AI intraday signals

ANTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ANTX
(Try 14 days for Free)

View a ticker or compare two or three

Compare

ANTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ANTX
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

ANTX is expected to report earnings to fall 16.86% to -35 cents per share on March 27

AN2 Therapeutics ANTX Stock Earnings Reports

Q4'24

Est.

$-0.36

Q3'24

Beat

by $0.02

Q2'24

Beat

by $0.13

Q1'24

Beat

by $0.06

Q4'23

Est.

$-0.57

The last earnings report on November 13 showed earnings per share of -43 cents, beating the estimate of -44 cents. With 1.25M shares outstanding, the current market capitalization sits at 29.84M.

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Managed Health Care

Address

1800 El Camino Real

Phone

+1 650 331-9090

Employees

Web

https://www.an2therapeutics.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
ACGL	101.83	1.78	+1.78%
Arch Capital Group Ltd
STRM	2.31	0.02	+0.87%
Streamline Health Solutions Inc
GDS	21.96	-0.24	-1.08%
GDS Holdings Limited
NVX	1.98	-0.04	-1.98%
NOVONIX Limited
ELVN	24.41	-0.51	-2.05%
Enliven Therapeutics

ANTX and Stocks

Correlation & Price change

A.I.dvisor tells us that ANTX and NKTX have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANTX and NKTX's prices will move in lockstep.

Ticker / NAME	Correlation To ANTX	1D Price Change %
ANTX	100%	N/A
NKTX - ANTX	26% Poorly correlated	-6.30%
CSLLY - ANTX	26% Poorly correlated	-3.76%
RANI - ANTX	25% Poorly correlated	-3.40%
CERO - ANTX	24% Poorly correlated	+52.40%
SCPX - ANTX	24% Poorly correlated	-8.61%
More